leadf
logo-loader
viewInnoCan Pharma
(
CSE:INNO
)

Innocan Pharma launches Derma CBD line in Europe

Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has launched their CBD derma line. Bincovich discusses where it is being made and the first areas of the world it is being rolled out to.

Bincovich also told gave Proactive an update on their Pharma work and how their capital raise is going.

Quick facts: InnoCan Pharma

Follow
CSE:INNO

Price: 1 CAD

Market Cap: $221.45 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Marble Financial’s subsidiary Inverite Verification records 80,000 monthly...

Marble Financial CEO Karim Nanji joined Steve Darling from Proactive to share news its subsidiary, Inverite Verification has reported achieved record growth and transaction volume milestones. Nanji telling Proactive in August the company surpassed 80,000 monthly transactions and recorded an...

8 hours, 17 minutes ago

2 min read